Reduced nicotine reward in obesity: cross-comparison in human and mouse
- PMID: 15719224
- DOI: 10.1007/s00213-005-2167-9
Reduced nicotine reward in obesity: cross-comparison in human and mouse
Abstract
Rationale: Tobacco use and obesity lead to significant morbidity and mortality.
Objective: This study was conducted to investigate the factors maintaining smoking behavior in lean and obese individuals by utilizing a mouse/human cross-validation model of nicotine reward.
Methods: In humans, a cigarette choice paradigm was used to examine the relative reinforcing value of nicotine in obese and non-obese smokers. Conditioned place preference (CPP) for nicotine was assessed in mice fed standard low fat rodent chow and mice rendered obese by a high fat diet.
Results: In humans, obese smokers self-administered nicotine via cigarettes significantly less often than non-obese smokers and showed attenuated hedonic effects of nicotine-containing cigarettes compared to denicotinized cigarettes. Similarly, mice exposed to a high fat diet did not exhibit nicotine CPP, relative to control mice. mRNA levels for mu-opiate and leptin receptors were also downregulated in the ventral tegmental area of these mice.
Conclusions: Together, these studies provide the first evidence for reduced nicotine reward in obese subjects and suggest that this may be mediated by dietary influences on the endogenous opioid system.
Similar articles
-
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.Psychopharmacology (Berl). 2006 Oct;188(3):355-63. doi: 10.1007/s00213-006-0504-2. Epub 2006 Sep 8. Psychopharmacology (Berl). 2006. PMID: 16960700 Clinical Trial.
-
Diet-induced obesity causes ghrelin resistance in reward processing tasks.Psychoneuroendocrinology. 2015 Dec;62:114-20. doi: 10.1016/j.psyneuen.2015.08.004. Epub 2015 Aug 11. Psychoneuroendocrinology. 2015. PMID: 26292268
-
Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking.Psychopharmacology (Berl). 2006 Mar;184(3-4):600-7. doi: 10.1007/s00213-005-0103-7. Epub 2005 Aug 2. Psychopharmacology (Berl). 2006. PMID: 16075290 Clinical Trial.
-
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.Psychopharmacology (Berl). 2005 Jun;180(1):41-8. doi: 10.1007/s00213-004-2136-8. Epub 2005 Jan 29. Psychopharmacology (Berl). 2005. PMID: 15682300 Clinical Trial.
-
Reward and inhibition in obesity and cigarette smoking: Neurobiological overlaps and clinical implications.Physiol Behav. 2023 Mar 1;260:114049. doi: 10.1016/j.physbeh.2022.114049. Epub 2022 Dec 5. Physiol Behav. 2023. PMID: 36470508 Free PMC article. Review.
Cited by
-
Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.Neuropsychopharmacology. 2013 Jan;38(2):302-12. doi: 10.1038/npp.2012.171. Epub 2012 Sep 12. Neuropsychopharmacology. 2013. PMID: 22968817 Free PMC article.
-
"Healthier health in more ways than one": Perspectives on a program for changing both smoking and obesity-related health behaviors.Eat Behav. 2024 Apr;53:101883. doi: 10.1016/j.eatbeh.2024.101883. Epub 2024 May 6. Eat Behav. 2024. PMID: 38733698 Free PMC article.
-
Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.Behav Pharmacol. 2008 Sep;19(5-6):630-40. doi: 10.1097/FBP.0b013e32830c3621. Behav Pharmacol. 2008. PMID: 18690117 Free PMC article.
-
Insulin, leptin and reward.Trends Endocrinol Metab. 2010 Feb;21(2):68-74. doi: 10.1016/j.tem.2009.08.004. Epub 2009 Oct 7. Trends Endocrinol Metab. 2010. PMID: 19818643 Free PMC article. Review.
-
Nicotine reduction revisited: science and future directions.Tob Control. 2010 Oct;19(5):e1-10. doi: 10.1136/tc.2009.035584. Tob Control. 2010. PMID: 20876072 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials